Role of therapeutic plasma exchange (TPE) in the management of anti-glomerular basement membrane (anti-GBM) disease: A case series from tertiary-care hospital in India.
- 1Department of Transfusion Medicine, Medanta - The Medicity, Gurgaon, Haryana, India.
- 2Department of Transfusion Medicine, Goa Medical College, Bambolim, Goa, India.
- 3Department of Nephrology and Kidney Transplant Medicine, Medanta - The Medicity, Gurgaon, Haryana, India.
Abstract
Anti-glomerular basement membrane (anti-GBM) disease is an uncommon, autoimmune disease in which IgG antibodies bind to intrinsic antigens distributed along the length of glomerular basement membrane. It is characterized by rapid and progressive loss of renal function. The rationale of management is to suppress renal inflammation and production of autoantibodies (with immunosuppression), as well as removal of circulating pathogenic autoantibodies (with therapeutic plasma exchange [TPE]). However, there is a paucity of data on the role of TPE in the management of anti-GBM cases worldwide. Three consecutive anti-GBM patients were admitted with common complaints of high-grade fever, chills, hematuria, and low urine output. In view of decreased renal function and strong suspicion of anti-GBM disease, the treatment protocol was initiated in accordance with the international Kidney Disease Improving Global Outcomes guidelines. All three patients had crescentic glomerulonephritis (crescents in more >80% glomeruli) on renal biopsy. Management was initiated with TPE and immunosuppression (methylprednisolone) and cytotoxic drug (cyclophosphamide). TPE was done until the anti-GBM antibody titer dropped to <10. Case 1 underwent TPE daily (12 sessions), and case 2 and case 3 underwent 14 and 9 sessions, respectively, of TPE alternating with dialysis. Renal function improved in cases 1 and 2, and routine dialysis was discontinued. Case 3 showed improvement initially until TPE was done; however, the disease progressed to end-stage renal disease, and the patient remains dialysis dependent. None of the patients had adverse reactions during TPE. TPE is an effective and safe conjunct in the treatment of anti-GBM disease as shown by complete reversal in two cases and partial response in the third patient.
Related
- The secretory peptidase inhibitor R3HDML fine-tunes p38 MAPK signaling to maintain glomerular basement membrane architecture during renal aging and disease
- Recurrent Corneal Erosion Syndrome in Epithelial Basement Membrane Dystrophy: Current Treatments and Mechanism-Guided Therapeutic Opportunities
- Glomerular Properdin Deposition Suggests a Favorable Therapeutic Response to Tonsillectomy and Steroid Pulse Therapy in IgA Nephropathy
- Comparative long-term outcomes of kidney transplantation from donors with isolated microscopic hematuria and thin basement membrane disease versus donors with isolated microscopic hematuria and normal histology: the largest cohort analysis to date.
- Microbiota-Associated Metabolites as Immunometabolic Regulators of Glomerular Inflammation: Disease-Specific Mechanisms and Therapeutic Opportunities.
BibTeX
@article{pawar2026role,
title = {{Role of therapeutic plasma exchange (TPE) in the management of anti-glomerular basement membrane (anti-GBM) disease: A case series from tertiary-care hospital in India.}},
author = {Samruddhi Pawar and Aseem Kumar Tiwari and Sunil Golia and Geet Aggarwal and Shubham Gupta and Gunjan Bhardwaj and Shyam Bihari Bansal},
journal = {Asian journal of transfusion science},
year = {2026},
month = jun,
doi = {10.4103/ajts.ajts_216_24},
url = {https://europepmc.org/article/MED/42953509},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Role of therapeutic plasma exchange (TPE) in the management of anti-glomerular basement membrane (anti-GBM) disease: A case series from tertiary-care hospital in India.
AU - Samruddhi Pawar
AU - Aseem Kumar Tiwari
AU - Sunil Golia
AU - Geet Aggarwal
AU - Shubham Gupta
AU - Gunjan Bhardwaj
AU - Shyam Bihari Bansal
PY - 2026
DA - 2026/06/02
JO - Asian journal of transfusion science
DO - 10.4103/ajts.ajts_216_24
UR - https://europepmc.org/article/MED/42953509
AB - Anti-glomerular basement membrane (anti-GBM) disease is an uncommon, autoimmune disease in which IgG antibodies bind to intrinsic antigens distributed along the length of glomerular basement membrane. It is characterized by rapid and progressive loss of renal function. The rationale of management is to suppress renal inflammation and production of autoantibodies (with immunosuppression), as well as removal of circulating pathogenic autoantibodies (with therapeutic plasma exchange [TPE]). However, there is a paucity of data on the role of TPE in the management of anti-GBM cases worldwide. Three consecutive anti-GBM patients were admitted with common complaints of high-grade fever, chills, hematuria, and low urine output. In view of decreased renal function and strong suspicion of anti-GBM disease, the treatment protocol was initiated in accordance with the international Kidney Disease Improving Global Outcomes guidelines. All three patients had crescentic glomerulonephritis (crescents in more >80% glomeruli) on renal biopsy. Management was initiated with TPE and immunosuppression (methylprednisolone) and cytotoxic drug (cyclophosphamide). TPE was done until the anti-GBM antibody titer dropped to <10. Case 1 underwent TPE daily (12 sessions), and case 2 and case 3 underwent 14 and 9 sessions, respectively, of TPE alternating with dialysis. Renal function improved in cases 1 and 2, and routine dialysis was discontinued. Case 3 showed improvement initially until TPE was done; however, the disease progressed to end-stage renal disease, and the patient remains dialysis dependent. None of the patients had adverse reactions during TPE. TPE is an effective and safe conjunct in the treatment of anti-GBM disease as shown by complete reversal in two cases and partial response in the third patient.
SN - 0973-6247
SN - 1998-3565
ER -